Dix C J, Jordan V C
Endocrinology. 1980 Dec;107(6):2011-20. doi: 10.1210/endo-107-6-2011.
The effect of sc injections (25 microgram) of estradiol benzoate, monohydroxytamoxifen [1-(4 beta-dimethylaminoethoxyphenyl)1-(4-hydroxyphenyl)-2-phenylbut-1-ene] and tamoxifen [trans-1-(4 beta-dimethylaminoethoxyphenyl)1,2-diphenylbut-1-ene] every 12 h on uterine wet weight, DNA, and cytoplasmic estrogen and progesterone receptor levels has been studied in the immature rat for up to 90 h. Estradiol benzoate produced a 4-fold rise in uterine wet weight, with a doubling of uterine DNA within 48 h. Tamoxifen and monohydroxytamoxifen doubled uterine weight, with a small rise in uterine DNA. Cytoplasmic estrogen receptor levels were reduced within 24 h by all treatments. Estradiol benzoate and monohydroxytamoxifen produced a maximal rise in nuclear estrogen receptor levels within 8 h, followed by a rapid decline to control levels within 80 h. Tamoxifen produced a slower rise in nuclear estrogen receptor levels and never reached the levels achieved by estradiol or monohydroxytamoxifen. The level of nuclear tamoxifen-estrogen receptor complexes slowly decreased with time. In each case, the cytoplasmic progesterone receptor levels increased as nuclear estrogen receptor levels decreased. Cycloheximide (5 microgram/2 h for 8 h before and 20 h after the first estrogen or antiestrogen injection) was used to determine the effect of protein synthesis inhibition on the hormone receptor profiles. Progesterone receptor synthesis was inhibited by cycloheximide. Cycloheximide did not affect translocation, but produced a rapid decrease in nuclear estrogen receptor levels. The results suggest that without the continual translocation of estrogen receptors from the cytoplasm, the antiestrogen-estrogen receptor levels in the nuclear compartment decrease because of destruction or processing. The nuclear antiestrogen-estrogen receptor pool is therefore not static but dynamic. High affinity ligand-estrogen receptor complexes are readily processed in the nucleus to effect progesterone receptor synthesis in the cytoplasm; however, this series of biochemical reactions is only secondary to the fundamental events essential for cell division. After an initial increase in cytoplasmic steroid receptor synthesis by estrogen or antiestrogen, there is a gradual reduction in total cytoplasmic and nuclear estrogen receptor complexes in response to continual nuclear stimulation. This reduction, in turn, reduces progesterone receptor synthesis.
在未成熟大鼠中,研究了每12小时皮下注射(25微克)苯甲酸雌二醇、单羟基他莫昔芬[1-(4β-二甲基氨基乙氧基苯基)-1-(4-羟基苯基)-2-苯基丁-1-烯]和他莫昔芬[反式-1-(4β-二甲基氨基乙氧基苯基)-1,2-二苯基丁-1-烯],长达90小时对子宫湿重、DNA以及细胞质雌激素和孕激素受体水平的影响。苯甲酸雌二醇使子宫湿重增加4倍,48小时内子宫DNA增加一倍。他莫昔芬和单羟基他莫昔芬使子宫重量增加一倍,子宫DNA略有增加。所有处理在24小时内均使细胞质雌激素受体水平降低。苯甲酸雌二醇和单羟基他莫昔芬在8小时内使核雌激素受体水平达到最大升高,随后在80小时内迅速降至对照水平。他莫昔芬使核雌激素受体水平升高较慢,从未达到苯甲酸雌二醇或单羟基他莫昔芬所达到的水平。核他莫昔芬-雌激素受体复合物水平随时间缓慢下降。在每种情况下,随着核雌激素受体水平下降,细胞质孕激素受体水平升高。使用环己酰亚胺(在首次注射雌激素或抗雌激素之前8小时和之后20小时,每2小时5微克)来确定蛋白质合成抑制对激素受体谱的影响。环己酰亚胺抑制孕激素受体合成。环己酰亚胺不影响转位,但使核雌激素受体水平迅速下降。结果表明,由于破坏或加工,如果没有雌激素受体从细胞质持续转位,核区室中的抗雌激素-雌激素受体水平会降低。因此,核抗雌激素-雌激素受体库不是静态的而是动态的。高亲和力配体-雌激素受体复合物在细胞核中很容易被加工,以影响细胞质中孕激素受体的合成;然而,这一系列生化反应只是细胞分裂所必需的基本事件的次要反应。在雌激素或抗雌激素最初增加细胞质类固醇受体合成后,由于持续的核刺激,细胞质和核雌激素受体复合物总量会逐渐减少。这种减少反过来又会降低孕激素受体合成。